erbitux - cetuximab solution
(Cetuximab)Imclone Llc
Usage: Erbitux treats locally or regionally advanced and recurrent or metastatic squamous cell carcinoma of the head and neck, and K-Ras wild-type, EGFR-expressing metastatic colorectal cancer. Also indicated for BRAF V600E mutation-positive metastatic colorectal cancer with encorafenib after prior therapy.